AI assistant
Pulmatrix, Inc. — Director's Dealing 2022
Mar 3, 2022
35037_dirs_2022-03-03_db4e8704-93d9-4e4a-ae4d-bf7a4c3ccff7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2022-03-01
Reporting Person: Wasilewski Margaret (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | Stock Option (Right to Buy) | $5.72 | A | 21060 | Acquired | 2032-03-01 | Common Stock (21060) | Direct |
Footnotes
F1: The shares underlying this stock option will vest as follows: 25% of the options shall vest on the first anniversary of the grant date and 75% of the options shall vest in equal installments on the monthly anniversary date of each of the thirty-six (36) successive months after the first anniversary of the grant date, provided that the reporting person is providing services to the Issuer on the applicable vesting dates and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.